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Abstract  
 
Nurses are in a unique position to provide nutritional support and information to 
women with breast cancer who are undergoing chemotherapy, supporting them with 
making decisions regarding nutrition and diet. This narrative review evaluated the 
research evidence relating to: the nutritional challenges experienced during 
chemotherapy; and the most effective approaches for supporting women with dietary 
choice. Weight gain was identified as a specific problem for women undergoing 
chemotherapy. The evidence indicated that information about nutrition and food 
preparation support may go some way to assisting women in overcoming some of 
the nutrition related challenges experienced during chemotherapy treatment for 
breast cancer. However, further research is required to better inform person-centred 
nursing practice in this area. 
 
Keywords: breast cancer; chemotherapy; patient education; nutritional approaches; 
weight gain. 
 
Introduction  
   
Breast cancer is the most common cancer among females, with over 55,000 women 
being newly diagnosed every year in the UK (Cancer Research UK, 2017).  
Treatment commonly includes surgery, radiotherapy, chemotherapy and hormonal 
therapies (SIGN, 2013).  Being diagnosed with cancer may prompt an individual to 
make dietary changes (Beeken et al, 2016). Commencing chemotherapy has also 
been identified as a timely opportunity for receiving information about diet and weight 
management (James-Martin et al, 2014; Heinze and Williams, 2015; Kelly et al, 
2015). Improving nutrition in women during chemotherapy may provide benefits such 
as enhancing general health and wellbeing (Lawn et al, 2015); enabling women to 
better cope with chemotherapy side effects (Breast Cancer Care 2014; Boltong and 
Keast, 2015); and reducing the subsequent risk of cancer recurrence (Tramm et al, 
2011).   
 
However, evidence suggests women undergoing chemotherapy treatment for breast 
cancer lack nutrition-related information (Miyashita et al, 2015; Droog et al, 2014); 
and health professionals feel unprepared to provide this support (Murphy & Girot, 
2013; James-Martin et al, 2014).  No evidence-based guidelines on nutritional 
information for women undergoing chemotherapy for breast cancer currently exist. 
While there is some evidence from a systematic review that dietary counselling may 
improve energy and protein intake during chemotherapy for people with lung cancer 
(Kiss et al, 2014), benefits of nutritional interventions in chemotherapy are not clear 
(Isenring et al, 2013).   
 
Nurses are in a unique position to support women undergoing chemotherapy for 
breast cancer to make decisions regarding nutrition-related health behaviours (Bailey 
et al, 2012; RCN 2012), but need to understand the challenges facing women, and 
identify the most effective approach to provide support. 
 
This narrative review aimed to evaluate evidence regarding:  
1. The nutritional-related challenges experienced by women undergoing 
chemotherapy for breast cancer.  
2. The most effective approach to providing nutritional support for women who are 
receiving chemotherapy for breast cancer.  
 
Theoretical framework 
The review was underpinned by principles of person-centredness (McCance & 
McCormack, 2017), acknowledging the role of a health practitioner in supporting an 
individual to make informed choices and decisions regarding health-related 
behaviours about nutrition during cancer treatment. Rogers (1961) described the 
therapeutic relationship in which the practitioner creates a climate for change by a 
client. Nurses can therefore support an individual through making changes in health-
related behaviour, based on current available evidence (NHS 2016). 
 
 
Review methodology 
A systematic approach was followed for the review (Aveyard, 2014).  
Search strategy 
A comprehensive literature search was conducted using the electronic databases: 
PubMED; JBI; Cochrane; CINAHL; MEDline; PsychINFO; and Scopus. Search terms 
and combinations included: breast cancer; chemotherapy; diet; nutrition; side effects; 
lifestyle; interventions; quality of life. These terms were selected in accordance with 
the research aims and theoretical framework. Inclusion and exclusion criteria are 
presented in Table 1. A period of 5 years was chosen to understand current practice 
and the evidence relating to it. A flow chart showing the number of papers identified 
and finally appraised is provided in Figure 1.  Of the included studies, two were 
qualitative studies. A total of 2,770 women participated in the studies, most of which 
occurred outside of the UK.  
Appraisal of the literature 
Each literature source included in the review was independently evaluated using 
CASP critical appraisal tools (CASP, 2013) by the two authors. Themes were then 
identified for the review.  
 
Review findings   
 
The evidence from the reviewed papers is presented in several themes.  
Influence of chemotherapy on taste, appetite and nutritional status 
Coa et al. (2015) undertook a self-report survey with 173 women undergoing 
chemotherapy for breast cancer, reporting a decrease in appetite during 
chemotherapy in 36% of the women, and a statistically significant preference for a 
diet which was high in vegetables (p<0.01). In contrast, studies have identified 
women as eating foods with low nutritional content, including a diet low in fruit and 
vegetables, during chemotherapy (Ceccatto et al, 2014; Custodio et al, 2016; 
Ferreira et al, 2016). Cecatto et al. (2014) used the Brazilian healthy eating index to 
assess the diet of 78 women having breast cancer treatment showing a reduction in 
fruit intake (p=0.002), and concluding that diet quality is likely to change over the 
course of treatment. 
Sarenmalm et al. (2014) studied ‘burdensome symptoms’ in 206 women with breast 
cancer, identifying poor appetite, nausea, weight loss, taste changes, and 
swallowing difficulties as common symptoms in women undergoing chemotherapy.  
Spearman correlations showed associations between weight and lack of appetite 
(0.546), and changes in taste and nausea (0.503).  
A prospective study of 52 Australian women explored the effect of anthracycline 
and/or taxane chemotherapy on taste, food likes/dislikes, appetite, nutritional status 
and food intake (Boltong et al, 2014). Findings showed significant reductions in taste 
and appetite by cycle three (p= 0.043), although this was reversed by two months 
post- chemotherapy. Researchers also reported a significant association between 
taste function and kilojoule intake (p=0.008) and a significant association between 
reduced appetite and a reduced kilojoule and protein intake (p=0.002, and p=0.001 
respectively). Reduced appetite was also associated with a reduced body mass 
index and worsening nutritional status (Boltong et al, 2014).  
Weight gain 
Weight gain featured as a significant challenge for women in several studies. 
Evidence indicates that, even prior to chemotherapy, women with breast cancer 
presented with unhealthy metabolic features in relation to blood lipids, body 
composition and diet when compared with women without breast cancer (Bell et al, 
2014).  Greenlea et al. (2016) identified 65.5% of 1237 women with breast cancer as 
overweight at baseline. A retrospective chart review of 46 women with breast cancer 
(Hatch and Davies, 2014) identified a mean body mass index of 32.6kg/m2 and 
27.9kg/m2 in premenopausal and postmenopausal women respectively.  
Coa et al. (2015) reported that women with breast cancer were more likely than those 
with other types of cancer to report weight gain during chemotherapy (p<0.01).  Liu et 
al. (2014) described a trajectory of weight gain over the two years after chemotherapy, 
with women receiving cyclophosphamide, methotrexate and flurouracil exhibiting a 
steeper weight change than in those receiving anthracycline-based chemotherapy.  
The association between different types of chemotherapy and weight gain was also 
explored in a retrospective review of the medical records of 483 women from four 
Dutch hospitals over a 10 year period to 2010 (Winkels et al, 2014). The study revealed 
an average weight gain of 6kg in women during chemotherapy; women who received 
anthracyclines and taxanes treatment were more likely to gain weight than those who 
received anthracycline therapy alone. The authors surmised that, as women having 
anthracyclines and taxanes undergo a longer treatment duration, they are exposed to 
treatment and side effects for longer. A further study of 1237 women undergoing 
taxane therapy, also reported chemotherapy-induced peripheral neuropathy as more 
likely to occur in women who were overweight compared with women who were of a 
healthy weight, at 24 months post-chemotherapy (Greenlea et al. 2016). 
Kwok et al. (2015) used semi-structured interviews to explore the experiences, dietary 
information and support needs of 17 women who gained weight during chemotherapy. 
Women talked of not being informed that they might experience weight gain during 
their chemotherapy treatment, and some anticipated weight loss. Lack of physical 
activity due to fatigue, and changes to their usual diet as result of food cravings and 
comfort eating, were identified as leading to weight gain. In a phenomenological study 
of 12 women treated for breast cancer, women described themselves as being in 
transition between their former well-known body and a current strange and demanding 
body, caught in a dilemma where medication that contributed to long term survival, 
also led to weight gain and resultant self-blame (Pedersen et al, 2016). 
Approaches to providing nutritional support 
  
Studies of dietary interventions during chemotherapy for breast cancer included 
those supporting women to manage their body weight, make changes to their diet 
during and beyond their treatment, the use of dietary supplements, and outcomes of 
nutritional education programmes.  
 
Villarini et al. (2012) undertook an intervention study that aimed to prevent weight 
gain during chemotherapy treatment for breast cancer. The researchers compared 
findings from 47 women in the intervention group who participated in cooking classes 
and ate two low energy meals over the duration of their chemotherapy treatment, 
with 47 women in a control group who received dietary information and attended 
basic cooking classes.  The intervention group lost an average of 2.8kg, significantly 
more weight than those in the control group (p=0.0004).  
 
Arends et al. (2014) investigated the impact of a support programme consisting of six 
theory classes and two 3.5 hour cookery classes on dietary change in women 
undergoing chemotherapy for breast cancer. By month six, the average fruit and 
vegetable intake of those who participated in the support programme was almost 
200g greater than those in the control group who received standard nutritional 
advice. 
 
Dietary supplement use during chemotherapy was examined in two studies.  In one 
placebo controlled trial, Valadares et al. (2013) evaluated the effect of daily Agaricus 
sylvaticus (a type of mushroom) supplement on chemotherapy side effects in a study 
of 46 women. The intervention group were 80% less likely to have nausea and 
vomiting, 92.8% less likely to have problems with bowel function, and 20% less likely 
to have poor appetite than the control group. In a study of fish oil supplementation, 
Suzumura et al. (2016) reported significantly enhanced respiratory function (p<0.05), 
and significantly lower blood lactate concentration (p<0.05) in women in the 
intervention group compared to the control group who did not take the supplement.  
 
A further randomized control trial (de Groot et al, 2015) evaluated the effects of short 
term fasting during chemotherapy, comparing side effects and toxicity indicators in 
an intervention group who fasted (n=7) and control group (n=6) who did not fast. At 
seven days post-chemotherapy, erythrocyte and thrombocyte counts were 
significantly higher in the intervention group who fasted 24 hours prior to and 
following chemotherapy (p= 0.007; p= 0.00007 respectively). Although the authors 
suggested that fasting reduced the destruction of healthy circulating cells, and may 
reduce haematological toxicity by protecting CD3- and CD45+ cells from 
chemotherapy-related damaged by chemotherapy, the study sample is small.  
 
Discussion  
The review has identified evidence that women may face various nutritional 
challenges during chemotherapy for breast cancer, particularly in relation to taste, 
appetite, nutritional status, and weight gain.  Qualitative evidence regarding the 
experience and impact of weight gain on women as a result of chemotherapy 
indicates a role for nurses in providing lifestyle and emotional support to women 
during treatments. This evidence could suggest that a person-centred approach to 
practice could support women in meeting their needs during chemotherapy for breast 
cancer.   Unfortunately, none of the studies in this review included evidence from a 
nursing perspective. A small number of controlled trials provided evidence that 
information and education regarding food preparation and diet may influence the 
eating habits of women having chemotherapy for breast cancer, enabling women to 
better manage their weight during treatment. However the studies are small, and 
often use poorly validated tools. Nevertheless, a person-centred approach to 
practice could enable nurses to support women having chemotherapy to identify their 
nutrition needs. The evidence is limited by relatively small sample groups in studies 
of supplement use and fasting during chemotherapy. No conclusions can, therefore, 
be drawn from this particular evidence, and further work with larger populations is 
required. Furthermore, it is notable that the studies do not focus on the 
gastrointestinal effects of chemotherapy nor the impact of other medications given 
alongside chemotherapy, such as corticosteroids which are likely to contribute to 
weight gain.  
 
Conclusions and implications for practice 
Making positive choices about nutrition may enhance health and wellbeing in women 
undergoing chemotherapy for breast cancer. This is a key time when a woman may 
be open to making changes to improve her health, but may also be living with the 
physical and emotional effects of cancer and its’ treatment. Nurses have the 
opportunity to deliver individualised person-centred care as they build strong 
relationships with women having chemotherapy over a period of time. Exploring 
nutrition and dietary challenges and solutions may be a key step to supporting 
women with breast cancer to make longer term changes towards healthy eating 
habits. 
 
More research evidence is required to explore the work of nurses in relation to 
nutrition and lifestyle support for patients during cancer treatment, and those living 
with and beyond cancer (James-Martin et al, 2014; Scottish Government, 2016).   
 
Limitations  
This narrative review is limited by its focus on nutrition. The studies included do not 
report on the effect of chemotherapy on physical activity and the effect of that this 
can have on the weight of participants. 
 
Key Points 
 Many women who are having chemotherapy for breast cancer feel motivated 
to make lifestyle changes. 
 Weight gain is a common challenge that women experience when having 
chemotherapy treatment.   
 Nurses have a key role in supporting women throughout their breast cancer 
treatment. 
 Nutrition related support may assist women in living well during and beyond 
chemotherapy treatment for breast cancer.  
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Table 1 
 
 
Table 1: Inclusion and exclusion criteria for the search 
Inclusion Exclusion 
Peer reviewed Palliative care 
Available in full text Focus on breast cancer survival 
In English language Exercise and physical activity only 
Published 2012-2017 Not specific to breast cancer 
 Involved complex biological and 
physiological aspects of nutrition. 
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Table 2  
 
Author Aim Methods Findings Key points Limitations 
Arendes et al. 
(2014) 
The aim of the study 
was to increase fruit 
and vegetable (FV) 
intake for at least 6 
months in women with 
early breast  
118 participants  
 
RCT investigate the impact 
of a support programme 
consisting of six theory 
classes and two 3.5 hour 
cookery classes 
By month six, the average fruit and 
vegetable intake of those who 
participated in the support 
programme was almost 200g greater 
than those in the control group who 
received standard nutritional advice. 
A nutritional training 
intervention can 
increase fruit and 
vegetable intake 
 
Boltong et al. 
(2014) 
Investigate the effects 
of chemotherapy on 
taste, food preferences 
and nutritional 
outcomes of women 
receiving 
chemotherapy for 
breast cancer 
52 participants with stage I-II 
breast cancer 
 
Survey- Prospective cohort 
study. 
Standardized testing of taste 
perception, appetite and food 
liking. 
Energy intake decreased as a result 
of reduced taste function and 
appetite reduction 
Chemotherapy has an 
effect on taste and 
subsequently nutritional 
outcomes  
Study does not 
report on the use of 
anti-emetic 
medication and if 
this had an impact 
on appetite.  
Bell et al. (2013)  Aimed to characterize 
glucose metabolism in 
breast cancer patients 
near the initiation of 
chemotherapy. 
 
8 participants with stage I-II 
breast cancer  
Measures: Fasting blood, an 
oral glucose tolerance test, 
body composition, waist 
circumference, diet, 
cardiovascular fitness and 
muscle strength  
 
Breast cancer patients were 
abdominally obese, overweight and 
dyslipidemic. 
Compared to non-malignant matched 
females, fasting glucose and insulin 
concentrations were similar but 
fasting c-peptide was greater in 
patients.  
 
Even prior to 
chemotherapy, women 
with breast cancer 
presented with 
unhealthy metabolic 
features in relation to 
blood lipids, body 
composition and diet 
when compared with 
women without breast 
cancer 
Small study 
Coa et al. (2015) This cross-sectional 
study sought to 
describe the dietary 
changes experienced 
by cancer patients and 
to identify associations 
between these 
changes and common 
treatment symptoms 
A convenience sample of 
1199 cancer patients aged 
18 yr and older undergoing 
active treatment 
Descriptive analyses were 
conducted to estimate 
prevalence of dietary 
changes and chi-squared 
tests were used to examine 
associations between dietary 
changes and health 
outcomes. 
Approximately 40% of patients 
reported a decreased appetite since 
beginning treatment, and 67.2% of 
patients reported at least 1 
chemosensory alteration. Increased 
taste sensitivities were more 
common than decreased taste 
sensitivities, with increased 
sensitivity to metallic being the most 
common taste sensitivity (18.6%). 
Patients who had less energy or lost 
weight since beginning treatment 
women with breast 
cancer were more likely 
than those with other 
types of cancer to report 
weight gain during 
chemotherapy (p<0.01) 
Not all participants 
had breast cancer 
22 
 
were more likely than others to report 
treatment-related dietary changes. 
Ceccatto et al. 
(2014)  
To evaluate diet 
quality in women 
having adjuvant 
treatment for breast 
cancer.  
78 women treated in a 
hospital in Brazil  
 
Non randomized clinical 
study using the Brazilian 
healthy eating index  
The score of the Brazilian Healthy 
Eating Index Revised (BHEI-R) in the 
lowest tertile was 48.4 to 75.2 points, 
the second tertile was 75.7 to 81.8 
points, and the upper tertile was 82.0 
to 95.7 points. During treatment, of 
the women classified in the first 
tertile, 62% improved their diet score 
quality passing to the upper tertiles. 
Women classified in the second 
tertile, did not significantly alter the 
diet quality during the treatment, 
although 46% went to the third tertile. 
Patients classified in the third tertile 
significantly reduced the average 
score of the Index by 7.3 points 
during the treatment. Where the 
reduction in the diet quality was due 
to reducing the score of components 
Total fruits, Total vegetables, Dark 
Green and orange vegetables and 
Legumes, Total grains and Solid fats, 
Alcohol and Added sugar. 
Diet quality is likely to 
change over the course 
of treatment. 
Did not consider 
the impact of the 
type of 
chemotherapy 
treatment on diet 
quality.  
de Groot et al. 
(2015) 
The feasibility of STF 
and its effects on 
tolerance of 
chemotherapy in a 
homogeneous patient 
group with early breast 
cancer 
RCT 13 randomized to fast 
24h before and after 
commencing chemotherapy, 
or to eat according to the 
guidelines for healthy 
nutrition.  
STF was well tolerated. At seven 
days post-chemotherapy, erythrocyte 
and thrombocyte counts were 
significantly higher in the intervention 
group who fasted 24 hours prior to 
and following chemotherapy (p= 
0.007; p= 0.00007 respectively). 
STF during 
chemotherapy was well 
tolerated and fasting 
reduced the destruction 
of healthy circulating 
cells, and may reduce 
haematological toxicity. 
Small sample. 
Limited insight into 
the possible 
benefits of STF 
during 
chemotherapy. 
Greenlee et al. 
(2016) 
A component of the 
Pathways Study- a 
prospective study of 
women having 
treatment for invasive 
breast cancer. This 
paper focusses on 
associations between 
BMI and lifestyle 
1237 women receiving 
taxane treatment. Data 
measure: neurotoxicity 
symptoms, BMI and fruit and 
vegetable intake  
At baseline, 65.6% of the women 
were overweight or obese, 29.9% 
had low MVPA, 57.5% had low 
fruit/vegetable intake, and 9.5% 
reported antioxidant supplement use 
during treatment. Increased CIPN 
was more likely to occur in 
overweight and obese women 
CIPN more likely to 
occur in women who 
were overweight 
compared with women 
who were of a healthy 
weight, at 24 months 
post-chemotherapy 
Self-reporting bias 
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factors in 
chemotherapy-induced 
peripheral neuropathy 
(CIPN).  
 
Hatch & Davies 
(2014) 
Aim to evaluate weight 
change in women with 
breast cancer and to 
compare these 
findings to the 
pertinent literature.  
 
Date for 46 women- age, 
stage of cancer, weight, 
menopausal status, BMI and 
treatment.  
 
The median BMI of premenopausal 
women at diagnosis was 32.6 kg/m²². 
Postmenopausal women had a 
median BMI of 27.9 kg/m². 
The average weight loss 
between diagnosis and 
treatment completion 
was not significant in 
either group 
Pilot study 
Kwok A et al. 
(2014) 
 
 
The purpose of this 
study was to explore 
the experiences, 
dietary information and 
support needs of 
women who gain 
weight during 
chemotherapy 
treatment. 
 
Qualitative approach to 
explore the experiences of 
17 women from three 
Melbourne breast cancer 
clinics who gained weight 
between the commencement 
of chemotherapy and 2 
months after its completion. 
Semi-structured interviews 
exploring diet, weight 
changes, dietary information, 
support needs and sources. 
Thematic analysis of the 
interview data. 
 
Three themes: undesirable impacts 
of cancer treatment on diet and 
physical activity, surprise and 
concern associated with changes to 
weight and diet and insufficient 
dietary information and support. 
  
Models of dietetic 
practice and the 
provision of tailored 
dietary information 
should be explored. 
 
 
Liu N et al. 
(2014) 
 
To investigate the 
trajectory of weight 
change in Taiwanese 
women with breast 
cancer after starting 
chemotherapy and the 
impact of 
chemotherapy 
regimens on weight 
change while 
controlling for age, 
menopausal status, 
body mass index, 
lymph node 
involvement and 
Longitudinal, clinical 
observational study. Weights 
were repeatedly measured in 
147 women with breast 
cancer stages I–III. 
Hierarchical linear modelling 
was used to analyse these 
longitudinal data. 
 
Mean weight of participants 56.9 kg 
before chemotherapy and increased 
to 59.4kg at 8.5 months after the first 
chemotherapy followed by a 
decrease to 58.5kg at 21.5 months. 
During the last 25 months, weight 
increased slightly and never returned 
to the initial level. The highest weight 
gain were observed in women 
receiving cyclophosphamide, 
methotrexate and fluorouracil and 
was 2.9 kg (5%) vs. 0.9 kg (1%) in 
the anthracycline-based group. 
 
Women receiving 
cyclophosphamide, 
methotrexate and 
flurouracil exhibiting a 
steeper weight change 
than in those receiving 
anthracycline-based 
chemotherapy. 
Limited sample size 
and no control to 
compare weight 
changes in women 
without breast 
cancer.  
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changes in habits of 
dietary fat intake and 
exercise. 
 
Pederson et al. 
(2016) 
To describe the 
essential meaning of 
the phenomenon 
of weight and body 
shape changes 
in women treated 
for breast cancer 
and how these 
changes influence 
the women’s 
perception of body and 
self. 
 
Guided 
by existential 
phenomenology 
and descriptive 
life-world research.  
12 individual 
Interviews with women with 
changes in weight and 
body-shape 
Conducted at a 
Department of 
Oncology at a Danish 
University hospital.  
Three themes: (1)The body - a 
Demanding stranger; (2) Fighting to 
be the master in one’s own life and 
(3) Accepting the bodily changes. 
 
Women described 
themselves as being in 
transition between their 
former well-known body 
and a current strange 
and demanding body, 
caught in a dilemma 
where medication that 
contributed to long term 
survival, also led to 
weight gain and 
resultant self-blame 
 
Sarenmalm et 
al. (2014) 
To explore clusters of 
burdensome 
symptoms over time, 
the impact on health 
status and quality of 
life, and coping 
capacity in patients 
with breast cancer. 
 
Longitudinal study of 206 
women  
Three clusters of burdensome 
symptoms were identified: emotional 
symptom burden, gastrointestinal 
symptom burden, and unwellness 
symptom burden. The 
gastrointestinal symptom burden, 
with ‘‘change in the way food tastes’’ 
as a core symptom, was more often 
associated with chemotherapy. Less 
stable over time, the unwellness 
symptom burden could be interpreted 
as short- and long-term side effects 
of hormonal therapy.  
Poor appetite, nausea, 
weight loss, taste 
changes, and 
swallowing difficulties as 
common symptoms in 
women undergoing 
chemotherapy 
Limited 
generalizability  
Suzumura et al. 
(2016) 
 
Investigate the effect 
of fish oil (FO) 
supplementation, at 
RCT  
32 patients with breast  
The S group showed a significant 
increase in the maximal inspiratory 
and expiratory pressure (P ≤ 0.05 vs. 
Significantly enhanced 
respiratory function 
(p<0.05), and 
Limited 
generalizability  
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 4 g/day, on the 
respiratory 
performance and 
blood lipid profile 
randomized into control (C) 
and FO supplemented (S). 
Both groups underwent three 
respiratory evaluations and 
blood harvest (before 
chemotherapy—Day 0, and 
30 and 60 days after 
supplementation. 
Day 0) and in the maximum voluntary 
ventilation (P ≤ 0.05). Blood lactate 
concentration was significantly lower 
in the S group after 60 days, at rest, 
when compared to C (P ≤ 0.05). 
Plasma high-density lipoprotein 
(HDL) cholesterol concentration 
remained the same after 60 days of 
supplementation, while in the C 
group, it decreased significantly 
(P ≤ 0.05 Day 0 vs. Day 60). 
Triacylglycerol (TAG) plasma 
concentration in the S group was 
lower when compared to the C group 
(P ≤ 0.05 Day 60S vs. Day 60). 
significantly lower blood 
lactate concentration 
(p<0.05) in women in 
the intervention group 
compared to the control 
group (n=15) 
Valadares et al. 
(2013) 
 
 
 
To evaluate the effects 
of dietary 
supplementation of 
Agaricus sylvaticus on 
clinical and nutritional 
parameters in BC 
patients undergoing 
chemotherapy. 
A randomized, placebo-
controlled, double-blind, 
Brazil, September 2007 to 
July 2009. 46 patients with 
BC, Stage II and III, 
randomly assigned to receive 
either nutritional supplement 
with A. sylvaticus (2.1 g/day) 
or placebo. 
Patient’s supplemented with A. 
sylvaticus poor appetite decreased 
by 20% with no changes in bowel 
functions (92.8%), nausea and 
vomiting (80%) 
Dietary supplementation 
with A. sylvaticus 
improved nutritional 
status and reduced 
abnormal bowel 
functions, nausea, 
vomiting, and anorexia 
in patients with BC 
receiving chemotherapy. 
Limited 
generalizability  
Villarini et al. 
(2012) 
A randomized 
controlled study of 
adjuvant diet in BC 
patients undergoing 
chemotherapy. 
The  diet  was  
designed  to  prevent  
weight gain  during  
chemotherapy  
treatment.   
 
 
 
96 women of any age, 
receiving adjuvant 
chemotherapy without 
metastases. RCT  
The  intervention implied  
changing  their  usual  diet 
for the whole duration of 
chemotherapy, following 
cooking classes  and  having  
lunch  or  dinner  at  the  
study  centre  at least twice 
per week.  
The  women  in  the  intervention  
group  showed  a significant   
reduction   in   their   body   weight   
(2.9 kg   on average),  compared  
with  the  controls.   They  also  
significantly  reduced  body  fat  
mass,  waist  and  hip  
circumferences,   biceps,   
underscapular   and   suprailiac   
skinfolds compared with the women 
in the control group. 
Dietary  intervention  
during adjuvant 
chemotherapy for breast 
cancer is feasible and 
may prevent 
weight gain. 
 
 
Did not consider 
changes to diet and 
physical activity.  
Winkels et al. 
(2014) 
To assess Retrospective study of 739 
breast cancer patients. 
Median weight gain was Average weight gain of 
6kg in women during 
chemotherapy and 
Changes in food 
intake and physical 
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 whether weight gain 
depends on the type of 
chemotherapy. 
 
.  6 kg and  median weight loss was of 
3 kg. Women treated with 
anthracyclines 
taxanes gained 0.9 kg (95%CI 0.1, 
1.7) more than women treated with 
anthracyclines only.  
women who received 
anthracyclines and 
taxanes treatment were 
more likely to gain 
weight than those who 
received anthracycline 
therapy alone.   
activity were not 
studied.  
 
 
 
 
